Trial Details

TERMINATED
Basic Information
Clinical ID c2180
Identifier NCT03870334
Trial Title Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions DRUG: BT-11 880 mg|DRUG: Placebo
Participant Information
Sponsor NImmune Biopharma
City Tampa
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2021-05-05
Primary Completion Date 2022-08-26
Completion Date 2022-08-26